BLACKROCK ADVISORS LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 29 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$1,0000.0%1,5540.0%0.00%
Q3 2016$1,000
-98.9%
1,554
-96.5%
0.00%
Q2 2016$88,000
-17.0%
44,0970.0%0.00%
Q1 2016$106,000
-69.0%
44,097
-1.2%
0.00%
Q4 2015$342,000
+50.0%
44,622
+3.6%
0.00%
Q3 2015$228,000
-14.9%
43,068
+44.4%
0.00%
Q2 2015$268,00029,8290.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2016
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders